======= POU6F2 =======
== Gene Information ==
* **Official Symbol**: POU6F2
* **Official Name**: POU class 6 homeobox 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=11281|11281]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P78424|P78424]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=POU6F2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20POU6F2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/609062|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a member of the POU protein family characterized by the presence of a bipartite DNA binding domain, consisting of a POU-specific domain and a homeodomain, separated by a variable polylinker. The DNA binding domain may bind to DNA as monomers or as homo- and/or heterodimers, in a sequence-specific manner. The POU family members are transcriptional regulators, many of which are known to control cell type-specific differentiation pathways. This gene is a tumor suppressor involved in Wilms tumor (WT) predisposition. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.[provided by RefSeq, Oct 2009].
* **UniProt Summary**: Probable transcription factor likely to be involved in early steps in the differentiation of amacrine and ganglion cells. Recognizes and binds to the DNA sequence 5'-ATGCAAAT-3'. Isoform 1 does not bind DNA.
|Pou|
|Homeobox|
|ganglion mother cell fate determination|
|stem cell fate determination|
|stem cell fate commitment|
|cell fate determination|
|stem cell differentiation|
|visual perception|
|sensory perception of light stimulus|
|cell fate commitment|
|transcription by RNA polymerase II|
|transcription, DNA-templated|
|nucleic acid-templated transcription|
|RNA biosynthetic process|
|DNA-binding transcription factor activity|
|sensory perception|
|central nervous system development|
|nucleobase-containing compound biosynthetic process|
|heterocycle biosynthetic process|
|aromatic compound biosynthetic process|
|organic cyclic compound biosynthetic process|
|nervous system process|
|DNA binding|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|cellular nitrogen compound biosynthetic process|
|RNA metabolic process|
|cellular macromolecule biosynthetic process|
|macromolecule biosynthetic process|
|system process|
|gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|-1.77|
|[[:results:exp121|Golgicide-A 2μM R03 exp121]]|1.73|
|[[:results:exp111|R-DABN 8μM R03 exp111]]|2.01|
|[[:results:exp33|Rotenone 2μM R00 exp33]]|2.06|
|[[:results:exp208|Vinblastine 0.015μM R05 exp208]]|2.32|
|[[:results:exp244|SB743921 0.001μM R05 exp244]]|2.33|
|[[:results:exp93|DABN racemic mixture R03 exp93]]|2.83|
|[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|3.25|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 5783
* **Expression level (log2 read counts)**: 0.25
{{:chemogenomics:nalm6 dist.png?nolink |}}